Druggio Logo

Druggio

Japan Tobacco

Japan Tobacco is a global pharmaceutical company that focuses on the development and production of a wide range of drugs. Their primary emphasis is on treatments for diseases such as cancer, autoimmune disorders, cardiovascular diseases, and respiratory diseases. The company was established in 1999 and has since dedicated substantial resources to research and development in the pharmaceutical field. Please note that Japan Tobacco also has a major focus on tobacco products in addition to pharmaceuticals.

Japan Tobacco's Drugs

Enaroy

Approval date

2020/9/25

Treats

Corectim

Approval date

2020/1/23

Genvoya

Approval date

2016/6/17

Riona

Approval date

2014/1/17

Stribild

Approval date

2013/3/25

Truvada

Approval date

2005/3/23

Emtriva

Approval date

2005/3/23